Tag: neurovascular

Avicenna.AI announces total funding of US$10 million after securing Series A...

Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...

Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke

Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe. This is the first offering from...
cello ii catheter

CELLO II balloon guide catheter gains US FDA approval for peripheral...

The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can...
vis-m neurovascular imaging

First human cases performed with high-frequency imaging offering “unprecedented potential” in...

Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...

Fluidx Medical unveils new embolic for neurovascular use

Fluidx Medical has released information regarding the success of the IMPASS Embolic Device in in vivo research related to middle meningeal artery (MMA) embolisations...

Stryker launches “state-of-the-art” neurovascular lab to accelerate stroke care innovation

Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology...

Viz.ai partners with Cercare to support neurovascular clinical decision-making

Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...

Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment

Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...

iVascular launches new neurovascular portfolio with four CE-marked devices

Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...
vesalio

Vesalio announces EU MDR certification of neurovascular product lines

Vesalio has announced EU Medical Device Regulation (MDR) certification of its product lines—achieving this “significantly ahead” of its May 2023 deadline, according to a...

The inevitable growth of neurovascular robotics: Improved precision today, potential remote...

This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA. The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...

Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire

Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....

“Spectacular” unilateral proptosis treatment receives LINNC Paris Best Case Award

An “interesting case” of unilateral proptosis in a 14-year-old girl, treated using a hybrid approach via direct external carotid artery (ECA) puncture, was presented...

First Emboguard experiences reveal “excellent trackability and ease of use” in...

Having been launched earlier this year, the Emboguard balloon guide catheter (Cerenovus) was recently used in mechanical thrombectomy procedures for the first time. David...
amplifi artio

Artio Medical closes US$28 million in additional Series A financing

Artio Medical today announced the closing of US$28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised by the company to...

Wallaby acquires phenox to accelerate global expansion in neurovascular space

Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments. The acquisition is...

Bendit receives FDA 510(k) clearance for 0.021-inch steerable microcatheter

Bendit Technologies has received US Food and Drug Administration (FDA) 510(k) clearance of its Bendit21 microcatheter for treatment in the neuro, peripheral and coronary...

Guidewire-less neurovascular navigation system shows promise in rabbit aneurysm model

A new concept for navigating the neurovasculature, performed without the aid of a guidewire, has demonstrated its ability to be manoeuvred through tortuous vessels,...

Radial access is not just a new toy—it has come to...

This advertorial is sponsored by Medtronic. Upon gaining CE-mark approval in September of last year, the Rist radial access system (Medtronic) became the first dedicated...

Cerus Endovascular receives FDA clearance for 027 microcatheter products

Cerus Endovascular has received US Food and Drug Administration (FDA) 510(k) clearance for its 027 microcatheters, available in two lengths, expanding on a product...

Rapid Medical announces Eitan Havis as international president

Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular...

Bendit announces first-in-human use of Bendit21 neurovascular catheter in the USA

Bendit Technologies has announced the successful first use in the USA of its Bendit21 neurocatheter in a life-saving treatment. The case was completed at the University...

Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...

Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....

Biomodex launches synthetic clot product for neurovascular training

Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
neurovasc envi-sr trial china

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...
cello ii catheter

Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...

Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...

Q’Apel Medical launches Armadillo radial artery access platform

Q'Apel Medical announced today the launch of the Armadillo radial access system—the latest application of its SelectFlex technology and part of the SelectFlex family...
phenox longer stentriever

Phenox highlights benefits of longer stentriever devices with new study results

Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...
carotid disease stenting

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...
hemo bioengineering afentta

HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter

HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...
vesalio

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...
CereVasc eShunt system

CereVasc gains financing to support eShunt system to treat hydrocephalus

CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of an expanded Series A financing that raised US$43.9 million....
021 Contour Cerus endovascular

Cerus Endovascular’s 021 Contour neurovascular system approved in Europe

Cerus Endovascular has received CE Mark approval for its 0.021-inch Contour neurovascular system, compatible with smaller commercially available 021 microcatheters for the treatment of...

Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device

Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
diffusion pharmaceuticals

Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...

Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...
Artio Medical study

Artio Medical announces interim study results highlighting aneurysm occlusion device

Artio Medical has announced the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d'Isere, France. Presented by Blaise Baxter,...
cerus endovascular contour

Cerus Endovascular receives CE mark approval for its Contour Neurovascular System...

Cerus Endovascular has received CE mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The system incorporates...
imperative care financing series C

Imperative Care announces appointment of Brian Armijo as vice president of...

Imperative Care has announced that Brian Armijo has been appointed as vice president of operations. With more than 25 years of manufacturing and operations...
CorPath GRX Corindus

Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...

Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...

Vesalio reports expansion of international distributor network and Stroke Congress Exhibition...

Vesalio has announced that it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX

Corindus Vascular Robotics announces that it is seeking premarket clearance from the US Food and Drug Administration (FDA) to use the CorPath GRX System...

Are drug-coated balloons and drug-eluting stents the future in intracranial atherosclerotic...

Alternative treatment options for patients with intracranial atherosclerotic disease (ICAD) are needed, given its prevalence worldwide and the associated risk of recurrent ischaemic events....

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed...

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...